Skip to main content
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
30.56
+1.39 (4.77%)
At close: Apr 28, 2026, 4:00 PM EDT
30.80
+0.24 (0.79%)
After-hours: Apr 28, 2026, 7:50 PM EDT

Beam Therapeutics Revenue

In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth. Beam Therapeutics had revenue of $114.11M in the quarter ending December 31, 2025, with 279.52% growth.

Revenue (ttm)
$139.74M
Revenue Growth
+120.01%
P/S Ratio
21.91
Revenue / Employee
$273,470
Employees
511
Market Cap
3.06B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Arcutis Biotherapeutics 376.07M
Arcus Biosciences 247.00M
Nektar Therapeutics 55.23M
Alumis 24.05M
NewAmsterdam Pharma Company 22.50M
Revenue Rankings

BEAM News

More News